KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
Durham, North Carolina (April 17, 2023) – KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D. Mowery as Chief Executive Officer (CEO). Widely respected as an innovative biotech leader...
Read More